STD/ STD05 ? ? SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product name : STD/ STD05 Product Use Descrip- tion : Stodard Solvent Manufacturer or supplier's details Supplier Details Manufacturer Name The Berkebile Oil Company Address 1216 Red Brant Road Somerset, PA 15501, PO BOX 715 Phone 814-443-1656 Email This email address is being protected from spambots. You need JavaScript enabled to view it. Fax 814-443-2873 Chemtrec Emergency Tel # 800-424-9300 SECTION 2. HAZARDS IDENTIFICATION GHS Classification Flammable liquids : Category 4 Skin irritation : Category 2 Specific target organ tox- icity - single exposure : Category 3 (Central nervous system) Aspiration hazard : Category 1 GHS Label element Hazard pictograms : Signal word : Danger ? Hazard statements : H227 Combustible liquid. H304 May be fatal if swallowed and enters airways. H315 Causes skin irritation. H336 May cause drowsiness or dizziness. STD/ STD05 ? ? Precautionary statements : Prevention: P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/ eye protection/ face protection. Response: P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 + P312 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/ physician if you feel unwell. P331 Do NOT induce vomiting. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P362 Take off contaminated clothing and wash before reuse. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam for extinction. Storage: P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P403 + P235 Store in a well-ventilated place. Keep cool. P405 Store locked up. Disposal: P501 Dispose of contents/ container to an approved waste disposal plant. Potential Health Effects Primary Routes of Entry : Ingestion Inhalation Skin contact Eye Contact Aggravated Medical Con- dition : Preexisting disorders of the following organs (or organ systems) may be aggravated by exposure to this ma- terial: Skin Central nervous system Liver Kidney Respiratory disorders STD/ STD05 ? ? Symptoms of Overexpo- sure : Irritation Dermatitis Nausea Vomiting Diarrhoea Breathing difficulties Carcinogenicity: IARC No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. ACGIH No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH. OSHA No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA. NTP No component of this product present at levels greater than or equal to 0.1% is identified as a known or antic- ipated carcinogen by NTP. Emergency Overview Appearance liquid Color transparent, clear Odor characteristic, hydrocarbon-like, solvent-like Hazard Summary No information available. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Substance / Mixture : Mixture Hazardous components CAS-No. Chemical Name Concentration (%) 64742-47-8 Distillates (pet), hydrotreated light 0 - 100 64742-88-7 Solvent naphtha (pet), medium aliph. 0 - 100 Synonyms : Petroleum hydrocarbon solvent, Mineral Spirits, Stod- dard Solvent, Hydrotreated light distillate, Medium Aliphatic Solvent Naphtha, Special Notes: : Functionally equivalent petroleum streams may be found in this preparation at varying concentrations. STD/ STD05 ? ? SECTION 4. FIRST AID MEASURES General advice : Move out of dangerous area. Consult a physician. Show this safety data sheet to the doctor in atten- dance. Symptoms of poisoning may appear several hours later. Do not leave the victim unattended. If inhaled : Call a physician or poison control centre immediately. If unconscious place in recovery position and seek medical advice. In case of skin contact : If skin irritation persists, call a physician. If on skin, rinse well with water. If on clothes, remove clothes. In case of eye contact : Flush eyes with water as a precaution. Remove contact lenses. Protect unharmed eye. Keep eye wide open while rinsing. If eye irritation persists, consult a specialist. If swallowed : Keep respiratory tract clear. Do NOT induce vomiting. Do not give milk or alcoholic beverages. Never give anything by mouth to an unconscious per- son. If symptoms persist, call a physician. Take victim immediately to hospital. Most important symp- toms and effects, both acute and delayed : Irritation Dermatitis Nausea Vomiting Diarrhoea Breathing difficulties SECTION 5. FIREFIGHTING MEASURES Suitable extinguishing media : Carbon dioxide (CO2) Foam Dry chemical STD/ STD05 ? ? Water spray Unsuitable extinguishing media : High volume water jet Specific hazards during firefighting : Do not allow run-off from fire fighting to enter drains or water courses. Hazardous combustion products : Carbon dioxide (CO2) Carbon monoxide Smoke Fume Unburned hydrocarbons Specific extinguishing methods : Use a water spray to cool fully closed containers. Further information : Collect contaminated fire extinguishing water sepa- rately. This must not be discharged into drains. Fire residues and contaminated fire extinguishing wa- ter must be disposed of in accordance with local regu- lations. For safety reasons in case of fire, cans should be stored separately in closed containments. Special protective equip- ment for firefighters : Wear self-contained breathing apparatus for firefight- ing if necessary. NFPA Flammable and Combustible Liquids Classification: Combustible Liquid Class IIIA SECTION 6. ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures : Use personal protective equipment. Ensure adequate ventilation. Evacuate personnel to safe areas. Environmental precau- tions : Prevent product from entering drains. Prevent further leakage or spillage if safe to do so. If the product contaminates rivers and lakes or drains inform respective authorities. Methods and materials for containment and cleaning up : Contain spillage, and then collect with non- combustible absorbent material, (e.g. sand, earth, diatomaceous earth, vermiculite) and place in con- tainer for disposal according to local / national regula- tions (see section 13). Keep in suitable, closed containers for disposal. STD/ STD05 ? ? SECTION 7. HANDLING AND STORAGE Advice on safe handling : Avoid formation of aerosol. Do not breathe vapours/dust. Avoid exposure - obtain special instructions before use. Avoid contact with skin and eyes. For personal protection see section 8. Smoking, eating and drinking should be prohibited in the application area. Provide sufficient air exchange and/or exhaust in work rooms. Dispose of rinse water in accordance with local and national regulations. Conditions for safe sto- rage : Prevent unauthorized access. No smoking. Keep container tightly closed in a dry and well- ventilated place. Containers which are opened must be carefully re- sealed and kept upright to prevent leakage. Observe label precautions. Electrical installations / working materials must comp- ly with the technological safety standards. SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Components with workplace control parameters CAS-No. Components Value type (Form of exposure) Control parame- ters / Permissi- ble concentra- tion Basis 64742-47-8 Distillates (pet), hydro- treated light TWA 500 ppm 2,000 mg/m3 OSHA Z-1 ? ? TWA 200 mg/m3 (as total hydro- carbon vapor) ACGIH ? ? TWA 400 ppm 1,600 mg/m3 OSHA P0 64742-88-7 Solvent naphtha (pet), me- dium aliph. TWA 500 ppm 2,000 mg/m3 OSHA Z-1 ? ? TWA 200 mg/m3 (as total hydro- carbon vapor) ACGIH ? ? TWA 400 ppm OSHA P0 ? ? 1600 mg/m3 STD/ STD05 ? ? Personal protective equipment Respiratory protection : No personal respiratory protective equipment normally required. In the case of vapor formation use a respirator with an approved filter. Hand protection Eye protection : Eye wash bottle with pure water Tightly fitting safety goggles Skin and body protection : impervious clothing Choose body protection according to the amount and concentration of the dangerous substance at the work place. Hygiene measures : Avoid contact with skin, eyes and clothing. When using do not eat or drink. When using do not smoke. Wash hands before breaks and immediately after handling the product. SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance : liquid Color : transparent, clear Odor : characteristic, hydrocarbon-like, solvent-like Odor Threshold : No data available pH : not applicable Freezing Point (Melting point/range) : < -70 ?C (< -94 ?F) Boiling Point (Boiling point/boiling range) : 179 - 213.9 ?C (354 - 417.0 ?F) Flash point : 61 - 66 ?C (142 - 151 ?F) Evaporation rate : 0.04 ? STD/ STD05 ? ? n-Butyl Acetate Flammability (solid, gas) : No data available Burning rate : No data available Upper explosion limit : 6.0 - 7.0 %(V) Lower explosion limit : 0.7 - 0.8 %(V) Vapour pressure : 0.32 - 0.5 mmHg @ 20 ?C (68 ?F) Relative vapour density : > 1AIR=1 Relative density : 0.78 - 0.81Reference substance: (water = 1) Density : 0.780 - 0.803 g/cm3 @ 15 - 15.5 ?C (59 - 59.9 ?F) Bulk density : No data available Solubility(ies) Solubility in other sol- vents : No data available Partition coefficient: n- octanol/water : No data available Auto-ignition temperature : 233 - 315 ?C Thermal decomposition : No data available Viscosity SECTION 10. STABILITY AND REACTIVITY Reactivity : No dangerous reaction known under conditions of normal use. Chemical stability : Stable under normal conditions. Possibility of hazardous reactions : Vapours may form explosive mixture with air. Conditions to avoid : Keep away from heat, flame, sparks and other ignition ? ? STD/ STD05 ? ? sources. Extremes of temperature and direct sunlight. Incompatible materials : Strong oxidizing agents Strong acids strong alkalis Chlorine Oxygen SECTION 11. TOXICOLOGICAL INFORMATION Acute toxicity Components: 64742-47-8: Acute inhalation toxicity : Remarks: No data available Acute dermal toxicity : LD50 (rabbit, male and female): > 2,000 mg/kg Method: Fixed dose procedure GLP: yes 64742-88-7: Acute inhalation toxicity : LC50 (rat, male and female): > 5.28 mg/l Exposure time: 4 h Test atmosphere: vapour Method: Fixed concentration procedure GLP: yes Assessment: The component/mixture is low toxic after short term inhalation. Remarks: Information given is based on data obtained from similar substances. Acute dermal toxicity : LD50 (rabbit, male and female): > 2,000 mg/kg GLP: yes Assessment: The component/mixture is low toxic after single contact with skin. Remarks: Information given is based on data obtained from similar substances. Skin corrosion/irritation Product: ? ? STD/ STD05 ? ? Remarks: Irritating to skin. Components: 64742-47-8: Species: rabbit Exposure time: 24 h Method: In vivo Result: Irritating to skin. 64742-88-7: Species: rabbit Exposure time: 24 h Method: In vivo Result: Irritating to skin. GLP: yes Serious eye damage/eye irritation Product: Remarks: Vapours may cause irritation to the eyes, respiratory system and the skin. Components: 64742-47-8: Species: rabbit Result: No eye irritation Exposure time: 1 s Method: EPA OTS 798.4500 GLP: yes Remarks: No eye irritation 64742-88-7: Species: rabbit Result: Irritating to eyes. Respiratory or skin sensitisation Components: 64742-47-8: Test Type: Buehler Test Exposure routes: Dermal Species: guinea pig Method: In vivo Result: Does not cause skin sensitisation. GLP: yes 64742-88-7: Test Type: Buehler Test Species: guinea pig STD/ STD05 ? ? Method: In vivo Result: Did not cause sensitisation on laboratory animals. GLP: yes Remarks: Based on a similar product formulation. Germ cell mutagenicity Components: 64742-47-8: Genotoxicity in vivo : Test Type: Chromosome aberration assay in vivo Test species: rat (male and female) Cell type: Bone marrow Application Route: Intraperitoneal Exposure time: 6 - 48 hrs Dose: 0, 300, 1000, 3000 mg/kg bw Result: negative GLP: yes Germ cell mutagenicity- Assessment : Tests on bacterial or mammalian cell cultures did not show mutagenic effects. 64742-88-7: ? ? ? ? STD/ STD05 ? ? from similar substances. Genotoxicity in vivo : Test Type: Dominant lethal assay Test species: mouse (male) Application Route: Intraperitoneal Dose: 1 ml/kg Result: negative Test Type: Dominant lethal assay Test species: mouse (male) Application Route: Inhalation Exposure time: 6 h/d, 5 d/wk for 8 wks Dose: 0, 100, 400 ppm Result: negative Test Type: DNA damage and/or repair Test species: mouse (male) Application Route: Intraperitoneal Exposure time: 20 -22 h Dose: 0, 400, 2000, 4000 mg/kg Result: positive GLP: yes Germ cell mutagenicity- Assessment : Mutagenicity classification not possible from current data Carcinogenicity Components: 64742-47-8: Species: mouse, (male and female) Application Route: Dermal Exposure time: 105 wks Dose: 0, 25 mg/application Frequency of Treatment: 3 days/week LOAEL: 25 Result: Limited evidence of carcinogenic effects Symptoms: Local irritation, Dermal tumours Carcinogenicity - As- sessment : Carcinogenicity classification not possible from current data. 64742-88-7: Species: mouse, (male and female) Application Route: Dermal Exposure time: 105 wks Dose: 0, 25 mg Frequency of Treatment: 3 times/wk NOAEL: < 25 mg/application STD/ STD05 ? ? Result: evidence of carcinogenic activity Symptoms: Local irritation, Dermal tumours Carcinogenicity - As- sessment : Carcinogenicity classification not possible from current data. Reproductive toxicity Components: 64742-47-8: Effects on foetal devel- opment : Species: rat Application Route: Oral Dose: 0, 500, 1000, 1500, 2000mg/kg Duration of Single Treatment: 10 d General Toxicity Maternal: NOAEL: 500 mg/kg body weight Teratogenicity: NOAEL: 2,000 mg/kg body weight Developmental Toxicity: NOAEL: 1,000 mg/kg body weight Symptoms: Reduced body weight Method: OECD Test Guideline 414 Result: Developmental toxicity occurred at maternal toxicity dose levels, No teratogenic effects. Reproductive toxicity - Assessment : Animal testing did not show any effects on fertility. Embryotoxicity classification not possible from current data. 64742-88-7: ? ? STD/ STD05 ? ? Fertility: NOAEL: >= 1,500 mg/kg body weight Symptoms: Reduced maternal body weight gain. Re- duced offspring weight gain. Result: Animal testing did not show any effects on fertility., Embryotoxic effects and adverse effects on the offspring were detected. GLP: yes Test Type: Screening test Species: rat, male and female Application Route: Dermal Dose: 0, 165, 330, 494 mg/kg/day General Toxicity F1: NOAEL: >= 494 mg/kg body weight Fertility: NOAEL: >= 494 mg/kg body weight Method: OECD Test Guideline 421 Remarks: Information given is based on data obtained from similar substances. Effects on foetal devel- opment : Species: rat Application Route: Oral Dose: 0, 500, 1000, 1500, 2000 milligram per kilo- gram Duration of Single Treatment: 10 d General Toxicity Maternal: NOAEL: 500 mg/kg body weight Teratogenicity: NOAEL: 2,000 mg/kg body weight Developmental Toxicity: NOAEL: 1,000 mg/kg body weight Symptoms: Reduced body weight Method: OECD Test Guideline 414 Result: Developmental toxicity occurred at maternal toxicity dose levels, No teratogenic effects. Species: rat Application Route: Inhalation Dose: 0, 106, 364 ppm Duration of Single Treatment: 10 d Frequency of Treatment: 6 hr/day General Toxicity Maternal: NOAEC: >= 364 ppm Teratogenicity: NOAEC: >= 364 ppm Developmental Toxicity: NOAEC: >= 364 ppm Method: OECD Test Guideline 414 Result: No teratogenic effects. Remarks: Information given is based on data obtained from similar substances. Reproductive toxicity - Assessment : Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal experi- ments. STD/ STD05 ? ? STOT - single exposure Product:No data available Components: 64742-47-8: Exposure routes: Target Organs: Assessment: Remarks: Inhalation Central nervous system May cause drowsi- ness or dizziness., The substance or mixture is classified as specific target organ toxicant, sin- gle exposure, cate- gory 3 with narcotic effects. ? 64742-88-7: Exposure routes: Target Organs: Assessment: Remarks: Inhalation Central nervous system May cause drowsi- ness or dizziness., The substance or mixture is classified as specific target organ toxicant, sin- gle exposure, cate- gory 3 with narcotic effects. ? STOT - repeated exposure Product:No data available Components: 64742-47-8: No data available 64742-88-7: No data available Repeated dose toxicity Components: 64742-47-8: Species: rat, male LOAEL: 750 mg/kg Application Route: Oral Exposure time: 70 - 90 days Number of exposures: daily STD/ STD05 ? ? Dose: 0, 750, 1500, 3000 mg/kg/d GLP: yes Symptoms: weight loss, Liver effects, Stomach/intestinal disorders Species: rat, female NOAEL: 750 mg/kg Application Route: Oral Exposure time: 21 wks Number of exposures: daily Dose: 0, 325, 750, 1500 mg/kg/d GLP: yes Symptoms: weight loss, Liver effects, Stomach/intestinal disorders Species: mouse, male and female NOAEL: >= 1000 Application Route: inhalation (vapour) Exposure time: 90 d Number of exposures: 24 h/d, daily Dose: 0, 500, 1000 mg/m3 GLP: No data available Species: rat, male and female NOAEL: >=0,5 Application Route: Dermal Exposure time: 28 d Number of exposures: 6 h/d, 5 d/wk Dose: 0, 0.01, 0.05, 0.5 ml/kg bw/d Method: OECD Test Guideline 410 GLP: yes Symptoms: Local irritation Repeated dose toxicity - Assessment : Causes skin irritation. 64742-88-7: ? STD/ STD05 ? ? GLP: yes Symptoms: weight loss, Local irritation Species: rat, male and female NOAEL: >= 24 Application Route: Inhalation Test atmosphere: vapour Exposure time: 4 wks Number of exposures: 6 h/d, 5 d/wk Dose: 0, 24 mg/m3 GLP: yes Remarks: Information given is based on data obtained from similar substances. Species: rat, male and female NOAEL: >= 0.5 mg/l Application Route: Dermal Exposure time: 4 wks Number of exposures: 6 h/d, 5 d/wk Dose: 0, 1.01, 0.05, 0.5 ml/kg/day Method: OECD Test Guideline 410 GLP: yes Remarks: Information given is based on data obtained from similar substances. Repeated dose toxicity - Assessment : Causes skin irritation. Aspiration toxicity Components: 64742-47-8: May be fatal if swallowed and enters airways. 64742-88-7: May be fatal if swallowed and enters airways. Experience with human exposure Product: Further information Product: Remarks: Symptoms of overexposure may be headache, dizziness, tiredness, nau- sea and vomiting., Concentrations substantially above the TLV value may cause nar- cotic effects., Solvents may degrease the skin. ? STD/ STD05 ? ? SECTION 12. ECOLOGICAL INFORMATION Ecotoxicity Components: 64742-47-8: Toxicity to daphnia and other aquatic inverte- brates : EL50 (Daphnia magna (Water flea)): 1.4 mg/l Exposure time: 48 h Test Type: static test Analytical monitoring: yes Method: OECD Test Guideline 202 GLP: yes Toxicity to algae : EL50 (Pseudokirchneriella subcapitata (green algae)): 1 - 3 mg/l End point: Growth rate Exposure time: 72 h Test Type: static test Analytical monitoring: yes Method: OECD Test Guideline 201 GLP: yes 64742-88-7: Toxicity to fish : LL50 (Oncorhynchus mykiss (rainbow trout)): 2 mg/l Exposure time: 96 h Test Type: semi-static test Analytical monitoring: yes Method: OECD Test Guideline 203 GLP: yes Remarks: Information given is based on data obtained from similar substances. Toxicity to daphnia and other aquatic inverte- brates : EL50 (Daphnia magna (Water flea)): 1.4 mg/l Exposure time: 48 h Test Type: static test Analytical monitoring: yes Method: OECD Test Guideline 202 GLP: yes Toxicity to algae : EL50 (Pseudokirchneriella subcapitata): 1 mg/l ? STD/ STD05 ? ? End point: Growth rate Exposure time: 72 h Test Type: static test Method: OECD Test Guideline 201 GLP: yes Remarks: Information given is based on data obtained from similar substances. Ecotoxicology Assessment Persistence and degradability Components: 64742-47-8: 64742-88-7: Biodegradability : aerobic Concentration: 101 mg/l Biodegradation: 61 % Testing period: 10 d Exposure time: 28 d Lag phase: 5 d Test substance: Solvent naphtha (petroleum), heavy aromatic GLP: yes Bioaccumulative potential No data available Mobility in soil Components: 64742-88-7: Other adverse effects No data available Product: Regulation 40 CFR Protection of Environment; Part 82 Protection ? ? ? STD/ STD05 ? ? of Stratospheric Ozone - CAA Section 602 Class I Sub- stances Remarks ? This product neither contains, nor was manufactured with a Class I or Class II ODS as defined by the U.S. Clean Air Act Section 602 (40 CFR 82, Subpt. A, App.A + B). ? Additional ecological in- formation : No data available ? SECTION 13. DISPOSAL CONSIDERATIONS Disposal methods Waste from residues : Dispose of in accordance with all applicable local, state and federal regulations. For assistance with your waste management needs - including disposal, recycling and waste stream reduc- tion, contact NEXEO's Environmental Services Group at 800-637-7922. Contaminated packaging : Empty remaining contents. Dispose of as unused product. Do not re-use empty containers. Do not burn, or use a cutting torch on, the empty drum. SECTION 14. TRANSPORT INFORMATION IATA (International Air Transport Association): Not regulated as a dangerous good IMDG-Code: Not regulated as a dangerous good DOT (Department of Transportation): UN1268, PETROLEUM DISTILLATES, N.O.S., CBL, III Special Notes: : The flash point for this material is greater than 100 F (38 C). Therefore, in accordance with 49 CFR 173.150(f) non-bulk containers (<450L or <119 gal- lon capacity) of this material may be shipped as non- regulated when transported solely by land, as long as the material is not a hazardous waste, a marine pollu- tant, or specifically listed as a hazardous substance. STD/ STD05 ? ? SECTION 15. REGULATORY INFORMATION OSHA Hazards : Combustible Liquid, Toxic by inhalation., Harmful by ingestion., Harmful by skin absorption., Moderate skin irritant, Aspiration hazard WHMIS Classification : B3: Combustible Liquid D2B: Toxic Material Causing Other Toxic Effects EPCRA - Emergency Planning and Community Right-to-Know Act CERCLA Reportable Quantity *: Calculated RQ exceeds reasonably attainable upper limit. SARA 304 Extremely Hazardous Substances Reportable Quantity This material does not contain any components with a section 304 EHS RQ. SARA 311/312 Hazards : Fire Hazard Acute Health Hazard SARA 302 : SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302. SARA 313 : SARA 313: This material does not contain any chemi- cal components with known CAS numbers that exceed the threshold (De Minimis) reporting levels estab- lished by SARA Title III, Section 313. Clean Air Act The following chemical(s) are listed as HAP under the U.S. Clean Air Act, Section 12 (40 CFR 61): This product does not contain any chemicals listed under the U.S. Clean Air Act Section 112(r) for Accidental Release Prevention (40 CFR 68.130, Subpart F). The following chemical(s) are listed under the U.S. Clean Air Act Section 111 SOCMI Intermediate or Final VOC's (40 CFR 60.489): Clean Water Act The following Hazardous Substances are listed under the U.S. CleanWater Act, Sec- tion 311, Table 116.4A: ? ? ? STD/ STD05 ? ? 100-41-4 Ethylbenzene 0.001 % 91-20-3 Naphthalene 0.001 % 108-88-3 Toluene 0.0001 % The following Hazardous Chemicals are listed under the U.S. CleanWater Act, Section 311, Table 117.3: This product does not contain any toxic pollutants listed under the U.S. Clean Water Act Section 307 US State Regulations Massachusetts Right To Know No components are subject to the Massachusetts Right to Know Act. Pennsylvania Right To Know 64742-47-8 Distillates (pet), hydrotreated light 0 - 100 % 64742-88-7 Solvent naphtha (pet), medium aliph. 0 - 100 % New Jersey Right To Know 64742-47-8 Distillates (pet), hydrotreated light 0 - 100 % 64742-88-7 Solvent naphtha (pet), medium aliph. 0 - 100 % California Prop 65 WARNING! This product contains a chemical known to the State of California to cause cancer. 100-41-4 Ethylbenzene 91-20-3 Naphthalene WARNING: This product contains a chemical known to the State of California to cause birth defects or other reproductive harm. The components of this product are reported in the following inventories: Switzerland. New notified substances and declared preparations : y (positive listing) (The formulation contains substances listed on the Swiss Inventory) United States TSCA Inventory : y (positive listing) (On TSCA Inven- tory) Canadian Domestic Substances List (DSL) : y (positive listing) (All components of this product are on the Canadian DSL.) ? ? STD/ STD05 ? ? Australia Inventory of Chemical Substances (AICS) : y (positive listing) (On the inventory, or in compliance with the inventory) Japan. ENCS - Existing and New Chemical Substances Inventory : n (Negative listing) (Not in compliance with the inventory) Japan. ISHL - Inventory of Chemical Substances (METI) : n (Negative listing) (Not in compliance with the inventory) Korea. Korean Existing Chemicals Inventory (KECI) : y (positive listing) (On the inventory, or in compliance with the inventory) Philippines Inventory of Chemicals and Chemical Substances (PICCS) : y (positive listing) (On the inventory, or in compliance with the inventory) China. Inventory of Existing Chemical Substances in China (IECSC) : y (positive listing) (On the inventory, or in compliance with the inventory) STD/ STD05 ? ? SECTION 16. OTHER INFORMATION Further information Flammability Special hazard. 0 = not significant, 1 =Slight, 2 = Moderate, 3 = High 4 =Extreme, * = Chronic The information accumulated is based on the data of which we are aware and is believed to be correct as of the date hereof. Since this information may be ap- plied under conditions beyond our control and with which we may be unfamiliar and since data made become available subsequently to the date hereof, we do not assume any responsibility for the results of its use. Recipients are advised to confirm in advance of need that the information is current, applicable, and suita- ble to their circumstances. This MSDS has been prepared by Zach Sherbine Legecy MSDS: 100000003584 Material number: 16062033, 504685, 547181, 547078, 102908, 689350, 579410, 86044, 554168, 87270, 103638, 53769, 70882, 53847, 53779, 732913, 705005, 16044171, 102360, 662188, 695035, 694956, 53802, 16048211, 715890, 622831, 20598, 53282, 594821, 70889, 86526, 657860, 508484, 508223, 554298, 554296, 554191, 554167, 554131, 554106, 53856, 103641, 53556, 53224, 16046724, 16036244, 16033332, 127746, 101826, 20597, 20596, 85982, 70879, 102995, 102695, 504573, 754617, 20594 Key or legend to abbreviations and acronyms used in the safety data sheet ACGIH American Conference of Gov- ernment Industrial Hygienists LD50 Lethal Dose 50% AICS Australia, Inventory of Chem- ical Substances LOAEL Lowest Observed Adverse Effect Level DSL Canada, Domestic Sub- stances List NFPA National Fire Protection Agency NDSL Canada, Non-Domestic Sub- NIOSH National Institute for Occupational ? Instability H ea lth ? STD/ STD05 ? ? ? stances List ? Safety & Health CNS Central Nervous System NTP National Toxicology Program CAS Chemical Abstract Service NZloC New Zealand Inventory of Chemicals EC50 Effective Concentration NOAEL No Observable Adverse Effect Level EC50 Effective Concentration 50% NOEC No Observed Effect Concentration EGEST EOSCA Generic Exposure Scenario Tool OSHA Occupational Safety & Health Admin- istration EOSCA European Oilfield Specialty Chemicals Association PEL Permissible Exposure Limit EINECS European Inventory of Exist- ing Chemical Substances PICCS Philipines Inventory of Commercial Chemical Substances MAK Germany Maximum Concen- tration Values PRNT Presumed Not Toxic GHS Globally Harmonized System RCRA Resource Conservation Recovery Act >= Greater Than or Equal To STEL Short-term Exposure Limit IC50 Inhibition Concentration 50% SARA Superfund Amendments and Reau- thorization Act. IARC International Agency for Re- search on Cancer TLV Threshold Limit Value IECSC Inventory of Existing Chemi- cal Substances in China TWA Time Weighted Average ENCS Japan, Inventory of Existing and New Chemical Sub- stances TSCA Toxic Substance Control Act KECI Korea, Existing Chemical In- ventory UVCB Unknown or Variable Compositon, Complex Reaction Products, and Biological Materials <= Less Than or Equal To WHMIS Workplace Hazardous Materials In- formation System LC50 Lethal Concentration 50% ?